HC-X014

N/A

Report date: 2023/12/07 18:32:44
NME

Base Information

Drug NameHC-X014
Drug Alias NameHC-X014
ClassificationSmall molecules
Mechanisms of ActionPoly (ADP-Ribose) polymerase modulators
TargetsPoly (ADP-Ribose) polymerase
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHinova Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesHinova Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A